ArticleInternational journal of ophthalmology2020

Risk factors for an atherothrombotic event in patients with diabetic macular edema treated with intravitreal injections of bevacizumab.

Alon Tiosano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.